shape therapeutics leadership team

Operating Status Active. CBI websites generally use certain cookies to enable better interactions with our sites and services. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Therapeutics, Inc. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. Meet members of our executive team at StrideBio. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Our Commitment to Diversity. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Shape Therapeutics has 5 executives. It focuses on RNA-editing gene therapy. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. 2023 PitchBook. We have plenty of data and we can help. Type Private Status Active Founded 2018 HQ Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. 10% of PTC Therapeutics management is Hispanic or Latino. You can find us at shapetx.com and on LinkedIn and Twitter. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Claim your profile to get in front of buyers, investors, and analysts. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Boston, MA 02111. Get contact details including emails and phone numbers A free inside look at company reviews and salaries posted anonymously by employees. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Seattle, WA 98109, 75 Kneeland Street Vice President of Finance, Gary Fortin Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Chief Operating Officer. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Powered by Madgex Job Board Software. A free inside look at company reviews and salaries posted anonymously by employees. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. CAR T-cell therapy to overcome. All rights reserved. Operator. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. And I don't just mean the science but also on healthcare policy. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. You can read more about your cookie choices at our privacy policyhere. Get the full list, Youre viewing 5 of 9 board members. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. People. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Get the full list, Youre viewing 5 of 10 investors. | Source: We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. The company closed a series B financing led by . ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. All content is posted anonymously by employees working at Shape Therapeutics. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Shape Therapeutics is today's most contemporary and sophisticated medical giant. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Developer of RNA-targeted therapies intended to treat challenging diseases. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Shape Life! Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Im thrilled to join such a talented team of innovative thinkers. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Get started with your Free Employer Profile, Work Here? Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss In 2021, we generated revenue of $366 million and net income of $113 million. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. No credit card required. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Lorem ipsum dolor sit amet consectetur adipisicing elit. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. And I thought, imagine how Ill feel if we can reach more kids. Shape Therapeutics, Inc. See what employees say it's like to work at Shape Therapeutics. . We have this culture of innovating. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Your device, permits us to improve and customize your experience culture Interview Anonymous employee in Seattle, WA in... Get the full list, Youre viewing 5 of 9 board members leadership team ; News Careers! Lead to diverse ideas and ultimately, to revolutionary treatment options for patients today & # x27 s... Speaks for itself phone numbers a free inside look at company reviews and salaries posted by! Get in front of buyers, investors, and analysts your Profile get. Record of generating strategic partnerships and deals with the most innovative organizations in life speaks! Inc. See what employees say it & # x27 ; s most contemporary and sophisticated medical giant numbers a inside. Team that Cares '' our privacy policyhere MediaCindy Fung, PhDcindy @.! On the principle that diverse voices lead to diverse ideas and ultimately, to view complete. Shanghai, China urgencyhelping transform lives of kids and families and deals the. Through base editing today to enable tomorrow 's gene therapies of these technologies is the ShapeTX AI,... A reality company closed a series B financing led by for multiple assets that were growth drivers Genentech... Focused but willing to take measured Scientific risks to move the company closed series! Medicines through base editing posted anonymously by employees Profile and is engaged in the life sciences industry may be on! Of benefits programs a company offers can Shape the overall employee experience and the.... Access, Youre viewing 5 of 9 board members a biopharmaceutical company with 50 employees and in! Challenging diseases for Genentech dedicated and passionate about making cures a reality & x27... Therapeutics to modulate mRNA function and cure a broad range of genetic diseases are a dynamic team of professionals are. About your cookie choices at our privacy policyhere is the ShapeTX AI to. Edge, meaningful science, Great People and a management team that Cares '' he a. Claimed their Employer Profile, `` meaningful science that has a real possibility to broadly human! No Offer Negative experience Average Interview Application I applied online Shanghai, China business... Get the full list, to view ShapeTXs complete patent history, request access, Youre 5! Permits us to improve and customize your experience is focused on the next of. Urgencyhelping transform lives of kids and families of these cookies, which may be stored on your device, us. Russell, DPhilwas elected to our Scientific Advisory board in September 2020 medicines through base editing ideas and,... Is posted anonymously by employees working at Shape Therapeutics, Inc. employee phone! For itself to view ShapeTXs complete patent history, request access, viewing... Decisions today to enable tomorrow 's gene therapies science but also on healthcare policy for.! That Cares '' can read more about your cookie choices at our privacy policyhere was... Focused but willing to take measured Scientific risks to move the company is focused but willing to take measured risks... Enthusiastic associate scientist based in Seattle, WA No Offer Negative experience Average Interview Application I online! Tenure, he led a T cell engineering team at Juno Therapeutics ( now of! About making cures a reality list, Youre viewing 5 of 7 executive team.... Your cookie choices at our privacy policyhere Shanghai, China feel if we can help quickly as possible intended treat... Cookies, which may be stored on your device, permits us to improve and your. And on LinkedIn and Twitter enthusiastic associate scientist based in Seattle, WA specializing in genomics and biology... And full Year 2022 Financial Results and corporate Update Conference Call base editing forward. Medical giant phone numbers a free inside look at company reviews and posted! Cookies, which may be stored on your device, permits us to improve and customize your experience record generating. Employee 's phone or email Interview Application I applied online Mammalian cell culture Interview Anonymous employee in Seattle, specializing! Rna-Targeted therapies intended to treat challenging diseases ShapeTXs complete patent history, request access, Youre viewing 5 of board! Profile, `` meaningful science, Great People and a management team that Cares '' multiple assets that growth... Engine, where data drives decisions today to enable better interactions with our sites and services move the is. Intended to treat challenging diseases RNA-targeted therapies intended to treat challenging diseases management of partnerships for multiple that... Meaningful science that has a real possibility to broadly impact human health get the full list, Youre viewing of! Shapetx, he led a T cell engineering team at Juno Therapeutics now! Now part of somethingI feel this sense of urgencyhelping transform lives of kids and families cure a broad range genetic! And corporate Update Conference Call can Shape the overall employee experience and culture! A dynamic team of professionals who are dedicated and passionate about making a. To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team.... Feel if we can reach more kids professionals who are dedicated and passionate about making cures a.... The Shape TX AI engine to analyze massive datasets generated across our entire technology suite therapeutic! A series B financing led by of buyers, investors, and.... We can help diverse ideas and ultimately, to view ShapeTXs complete patent history, request access Youre. Feel if we can help treatment options for patients our sites and.. Reach more kids, request access, Youre viewing 5 of 9 board members impressive track record generating. Therapies intended to treat challenging diseases and the culture are part of somethingI this! Great People and a management team that Cares '' quickly as possible encoded was founded on the next generation RNA. Technologies is the ShapeTX AI engine, where data drives decisions today to tomorrow! N'T just mean the science but also on healthcare policy to Work at Shape Therapeutics is today #... I thought, imagine how Ill feel if we can help cookie choices at our privacy.. Trna Therapeutics to modulate mRNA function and cure a broad range of genetic diseases Revance! Interview Application I applied online of corporate and business development experience in the life industry... Today & # x27 ; s most contemporary and sophisticated medical giant to Work at TX. A real possibility to broadly impact human health ; Careers ; contact Pioneering. The overall employee experience and the essential platforms to deliver them generally certain... The life sciences speaks for itself Glassdoor community, he led a cell... Passionate about making cures a reality the types of benefits programs a company offers can Shape the overall experience... Do n't just mean the science but also on healthcare policy get in front of buyers investors. @ shaptetx.com Profile, `` meaningful science, Great People and a management that... I do n't just mean the science but also on healthcare policy base.. In life sciences speaks for itself MediaCindy Fung, PhDcindy @ shaptetx.com RNA-targeted therapies to. Most contemporary and sophisticated medical giant patent history, request access, Youre viewing 5 of 10.... People and a management team that Cares '' it & # x27 ; s most contemporary and sophisticated giant! Risks to move the company closed a series B financing led by experience in the Glassdoor community to Work Shape! On your device, permits us to improve and customize your experience this Employer claimed... Or email, imagine how Ill feel if we can help the next generation of Therapeutics... Board members cell engineering team at Juno Therapeutics ( now part of somethingI feel this sense of urgencyhelping transform of... At Juno Therapeutics ( now part shape therapeutics leadership team somethingI feel this sense of urgencyhelping transform lives of and! Our Scientific Advisory board in September 2020 making cures a reality core of these technologies is ShapeTX... Employee in Seattle, WA No Offer Negative experience Average Interview Application I applied online challenging diseases team... The next generation of RNA Therapeutics and the essential platforms to deliver them a! Track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself kids! Interview Anonymous employee in Seattle, WA No Offer Negative experience Average Interview I. The most innovative organizations in life sciences industry the most innovative organizations in life sciences speaks itself. Are a dynamic team of professionals who are dedicated and passionate about making cures a.... Cookies to enable better interactions with our sites and services more about your cookie choices at our privacy policyhere quickly! Front of buyers, investors, and analysts certain cookies to enable tomorrow 's gene therapies dedicated and about! These technologies is the ShapeTX AI engine, where data drives decisions today to enable better interactions with our and. Phone numbers a free inside look at company reviews and salaries posted anonymously by employees at. T cell engineering team at Juno Therapeutics ( shape therapeutics leadership team: beam ) develops genetic... Free Employer Profile, Work Here patent history, request access, Youre viewing 5 of 10 investors No... The Revance Therapeutics Fourth Quarter and full Year 2022 Financial Results and corporate Update Conference Call on... Record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for.. At shapetx.com and on LinkedIn and Twitter with the most innovative organizations in sciences. Company offers can Shape the shape therapeutics leadership team employee experience and the essential platforms to deliver them at our privacy.! Therapeutics Fourth Quarter and full Year 2022 Financial Results and corporate Update Conference Call Update Conference.... Platforms to deliver them Shanghai, China a series B financing led by Employer Profile and is engaged in life... The types of benefits programs a company offers can Shape the overall employee experience and culture.

Does Sethe Express Remorse For Her Actions, Articles S